Cargando…
The Microbiome in PDAC—Vantage Point for Future Therapies?
SIMPLE SUMMARY: Pancreatic cancer is a highly lethal cancer and less than 10% of patients survive the 5-year mark. The molecular and biological underpinnings leading to this dismal prognosis are well-described, however, translation of these findings with subsequent improvement of the poor prognosis...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739548/ https://www.ncbi.nlm.nih.gov/pubmed/36497456 http://dx.doi.org/10.3390/cancers14235974 |